Article Listing - Gilead Sciences traumatized by FDA panel review of HIV drug adefovir

FRENCH HEALTH SPENDING RISE

13 April 1992

French health care spending by the CNAM insurance fund rose 0.3% between December 1991 and January 1992. Spending in January...

STOCK MARKET COMMENTARY: NEW YORK

13 April 1992

NEW YORK: stock prices climbed throughout nearly the whole rep-orting week, closing with a 40-point or 1.2% rise, following slow...

BEIERSDORF SEES SALES AND PROFIT UP

13 April 1992

Profits at the north German drugs group Beiersdorf AG have incr-eased at an above-average rate in relation to good sales...

CHINESE MEDICAL SCIENCE VILLAGE

13 April 1992

A "medical science village" has started operation in Zhuhai in the Chinese province of Guangdong. The village covers an area...

ABBOTT 1st QTR NET EARNINGS LEAP 16%

13 April 1992

For the first quarter of 1992, US-based Abbott Laboratories recorded a 15.8% jump in net earnings to $294 million, on...

PATENT INFRINGEMENT SUIT OVER SANDOZ' ZADITEN

13 April 1992

The Tokyo District Court has issued a preliminary injunction against Kyowa Yakuhin Kogyo, Tatsumi Kagaku and Ohara Yakuhin Kogyo with...

GYNEX TO MARKET DELATESTRYL

13 April 1992

Gynex Pharma has acquired US marketing rights to Bristol-Myers Squibb's Delatestryl (testosterone) as a treatment for male hypogonadism and delayed...

EC APPROVAL FOR DOVONEX

13 April 1992

Denmark's Leo Laboratories has been granted marketing approval from the European Community's Committee for Proprietary Medicinal Products for its psoriasis...

LEON JOINS RESEARCHLIFE

13 April 1992

Alberta Leon has joined Italian R&D company Researchlife following her resignation as chief executive officer at Fidia.

PASTEUR MERIEUX HIB VACCINE

13 April 1992

Pasteur Merieux has launched Hemophilus influenzae type B conjugate vaccine, called Act-HIB, onto the French market.

Showing 94321-94330 of 95356 articles